09 December 2024

Raising the standard in therapy with psychedelics

Psychedelic substances like psilocybin (found in magic mushrooms), MDMA (commonly known as ecstasy), LSD (commonly known as acid), and ayahuasca have shown potential in treating conditions such as depression, post-traumatic stress disorder (PTSD), and addiction. These substances can induce profound psychological experiences that, when paired with psychotherapy — a form of talk therapy — have been proposed to lead to significant therapeutic benefits.

Vanessa Pinto

Miguel Ribeiro

Leveraging olfaction to study social behavior in the mouse

Host

Susana Lima, PhD, Neuroethology Lab


Venue

Seminar room

Ana Rocha

25 November 2024

Key brain circuit for female sexual rejection uncovered

Female mammals, such as rodents, accept mating attempts only during their fertile phase, and actively reject males outside this period. While the brain areas controlling sexual receptivity are well-studied, the mechanisms behind active rejection are less so.

Marta Vasconcelos

Anuraag Vazirani

21 November 2024

World experts reflecting on the future of pancreatic cancer treatment

“Surgery can cure”, said Markus Büchler, director of the newly opened Botton-Champalimaud Pancreatic Cancer Centre, in Lisbon, during his talk. Büchler was referring to a form of pancreatic cancer surgery called the “triangle operation”, which he invented and developed.

Why We Get Sick: Immune-mediated Modulation of Systemic Metabolism in Context of Disease

Host

Klaas van Gisbergen, PhD, Tissue Immunity Lab


Venue

Seminar room

Subscribe to Champalimaud Research
Loading
Please wait...